Bruce Cheson, MD, shares his enthusiasm about novel therapies in the management of chronic lymphocytic leukemia with practitioners who are entering the field. Dr Cheson looks beyond the available targeted therapies and stresses the importance of getting patients into clinical trials to develop novel strategies when patients do not respond to targeted therapies. He also looks to the future of CAR T-cell therapy and other immunotherapies in a "chemo-free world."
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Advice for Physicians Entering the Field of Chronic Lymphocytic Leukemia - Medscape - Feb 07, 2022.
Comments